PATENT CLAIM ANALYSIS

Application Number: 15936661
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "234100"]

Abstract:
Probiotic  Bifidobacterium  strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.

Claim (Index 51):
A method for treating a subject, the method comprising administering to the subject an oral formulation comprising isolated strain  Bifidobacterium longum  deposited with NCIMB under accession number NCIMB 41676, wherein the  Bifidobacterium longum  strain is in the form of a powder.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 90.0
- Lexical Diversity: 1.23529
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13468374', '12450427', '12450451', '10783020', '13468512']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.74611180312279
- 35 USC 102 Novelty (BERT): 0.6384946670512879
- Combined Prediction Score: 0.7353500895156398
- Mean Citation Score: 490.88943600000016
- Max Citation Score: 665.76715
- Similarity Product: 537.6945170883656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test